Viridian Therapeutics Inc
NASDAQ:VRDN

Watchlist Manager
Viridian Therapeutics Inc Logo
Viridian Therapeutics Inc
NASDAQ:VRDN
Watchlist
Price: 22.43 USD -12.76% Market Closed
Market Cap: 1.7B USD
Have any thoughts about
Viridian Therapeutics Inc?
Write Note

Viridian Therapeutics Inc
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Viridian Therapeutics Inc
Long-Term Debt Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Viridian Therapeutics Inc
NASDAQ:VRDN
Long-Term Debt
$17.5m
CAGR 3-Years
N/A
CAGR 5-Years
23%
CAGR 10-Years
68%
Abbvie Inc
NYSE:ABBV
Long-Term Debt
$58.5B
CAGR 3-Years
-8%
CAGR 5-Years
12%
CAGR 10-Years
15%
Gilead Sciences Inc
NASDAQ:GILD
Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Long-Term Debt
$56.9B
CAGR 3-Years
20%
CAGR 5-Years
15%
CAGR 10-Years
6%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Long-Term Debt
$114m
CAGR 3-Years
-39%
CAGR 5-Years
-27%
CAGR 10-Years
-18%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Long-Term Debt
$2.7B
CAGR 3-Years
11%
CAGR 5-Years
31%
CAGR 10-Years
17%

See Also

What is Viridian Therapeutics Inc's Long-Term Debt?
Long-Term Debt
17.5m USD

Based on the financial report for Jun 30, 2024, Viridian Therapeutics Inc's Long-Term Debt amounts to 17.5m USD.

What is Viridian Therapeutics Inc's Long-Term Debt growth rate?
Long-Term Debt CAGR 10Y
68%

Over the last year, the Long-Term Debt growth was 272%.

Back to Top